Drug Discovery

Refining spray drying setups to enhance energy efficiency serves as a primary manufacturing lever for reducing the global warming potential of oral drug delivery components. This technical advancement reflects a broader trend where the pharmaceutical industry is navigating a pivotal transition to

Automated monitoring systems can track organoid morphology in real-time, providing critical data points that are nearly impossible to capture through manual inspection. This technological leap, driven by the collaboration between Molecular Devices and STEMCELL Technologies, addresses the historical

Medulloblastoma is often the result of epigenetic malfunctions rather than direct DNA mutations, requiring a specialized focus on how genetic material is controlled. Medulloblastoma remains a formidable adversary in pediatric oncology, accounting for a significant portion of high-grade brain tumors

Computational modeling of brain tissue reveals that Alzheimer’s is characterized by a systemic breakdown of cell junction biology and physical barriers between neurons. This revelation comes at a time when neurology is shifting its focus from broad symptomatic treatment to the granular manipulation

Fixing the diversity gap in clinical research is primarily an engineering problem involving the reform of site selection and feasibility assessment processes. For several decades, the pharmaceutical and biotechnology sectors have struggled to enroll participant populations that accurately reflect

Evidence-based interventions for suicidal thoughts remain scarce because a culture of risk aversion has systematically limited the scope of human clinical trials. While modern medicine has made extraordinary leaps in treating terminal illnesses such as late-stage cancer or complex cardiovascular